Freedman Financial Associates’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-300
| Closed | -$1K | – | 487 |
|
|
2022
Q1 | $1K | Hold |
300
| – | – | ﹤0.01% | 482 |
|
|
2021
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 450 |
|
|
2021
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 469 |
|
|
2021
Q2 | $2K | Sell |
300
-600
| -67% | -$4K | ﹤0.01% | 446 |
|
|
2021
Q1 | $4K | Hold |
900
| – | – | ﹤0.01% | 410 |
|
|
2020
Q4 | $3K | Buy |
+900
| New | +$3K | ﹤0.01% | 426 |
|